Key points are not available for this paper at this time.
In this cross-sectional study, clinical performance studies at the time of approval were reported for approximately half of AI-enabled medical devices, yet the information was often insufficient for a comprehensive assessment of their clinical generalizability, emphasizing the need for ongoing monitoring and regular re-evaluation to identify and address unexpected performance changes during broader use.
Windecker et al. (2025) studied this question.